Skip to main content

Table 1 Clinicopathologic features of the 122 patients with PDAC

From: Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma

ParametersPatients with PDAC (n = 122)
Median age (range)69 (43–90)
Tumor location
 Head/body and tail71/51
Differentiation grade
TNM stage
Tumor size
Microvascular invasion
Lymphatic permeation
Perineural invasion
Nodal metastasis
Neoadjuvant chemotherapy
Adjuvant chemotherapy
Postoperative radiotherapy
  1. PDAC pancreatic ductal adenocarcinoma, G1 well-differentiated carcinoma, G2 moderately differentiated carcinoma, G3 poorly differentiated carcinoma, G4 undifferentiated carcinoma